NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球藥物依從性市場(按產品,藥物,地區):未來展望,行業趨勢,增長預測(到2030年)

Medication Adherence Market Research Report: By Product, Medication - Global Industry Analysis and Growth Forecast to 2030

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 971172
出版日期 內容資訊 英文 303 Pages
商品交期: 2-3個工作天內
價格
全球藥物依從性市場(按產品,藥物,地區):未來展望,行業趨勢,增長預測(到2030年) Medication Adherence Market Research Report: By Product, Medication - Global Industry Analysis and Growth Forecast to 2030
出版日期: 2020年09月01日內容資訊: 英文 303 Pages
簡介

全球藥物依從性市場預計將以15.5%的複合年增長率增長,到2019年達到23.1億美元,到2030年達到112.263億美元。市場的主要驅動力是慢性病的流行和醫療費用負擔的增加,特別是隨著新型冠狀病毒感染(COVID-19)的傳播。按區域劃分,北美國家是最大的市場,而亞太國家預計將迅速增長。

本報告分析了全球藥品依從性市場,系統概述和背景,基本市場結構和主要市場推廣/限制因素以及實際/預測的市場規模(在接下來的11年間),我們按產品,藥品(疾病)和地區,市場競爭狀況,主要公司的概況等調查詳細趨勢。

目錄

第1章分析背景

第2章分析方法

第3章執行摘要

  • 行業專家/KOL的觀點

第4章簡介

  • 市場細分的定義
    • 按產品
      • 以軟件為中心
      • 以硬件為中心
    • 按藥品
      • 心血管
      • 中樞神經系統(CNS)
      • 糖尿病
      • 腫瘤
      • 呼吸系統疾病
      • 胃腸道
      • 類風濕
      • 其他
  • 市場動態
    • 市場趨勢
      • 擴大藥物依從性應用程序的使用範圍
      • 通過患者儲蓄計劃提高對藥物依從性的認識
      • 藥物依從性系統和軟件日益普及
    • 促進因素
      • 對高級藥物依從系統的需求不斷增長
      • 慢性病患病率上升
      • 老年人口增加
      • 對衛生技術的需求增加
      • 擴大對個性化醫療的需求
      • 驅動因素對市場預測的影響分析
    • 抑制因素
      • 電子海圖/基於處方的藥物依從性系統:隱私和安全問題
      • 新興國家的醫療基礎設施不足
      • 分析限制因素對市場預測的影響
    • 市場機會
      • 遍佈全球的未開發藥物依從性市場龐大
  • COVID-19對依從性市場的影響
    • COVID-19場景
  • 波特的五力分析

第5章世界市場:市場規模和預測

  • 按產品
    • 以軟件為中心:按類型
    • 以硬件為中心:按設備
    • 以硬件為中心:通過包裝
  • 按藥品
  • 按地區

第6章北美市場:市場規模和預測

第7章歐洲市場:市場規模和預測

第8章亞太市場:市場規模和預測

第9章拉丁美洲市場:市場規模和預測

第10章中東/非洲市場:市場規模和預測

第11章主要國家的藥物依從性市場

  • 美國市場
    • 按產品
    • 按藥品
  • 加拿大市場
  • 德國市場
  • 法國市場
  • 西班牙市場
  • 英國市場
  • 意大利市場
  • 日本市場
  • 中國市場
  • 印度市場

第12章藥物依從性產品的分析

  • 以硬件為中心的產品
    • Philips Automated Medication Dispenser
      • 概述
      • 優勢
      • 缺點
    • 2net Hub
    • Omnicell XT
    • Smart Pill Bottle
    • Nomi Pill Bottle
    • Cardinal Health Repackaging Solutions
    • Dispill
  • 以軟件為中心的產品
    • RelayRx PriorAuthPlus
    • Adherence Performance Solution
    • eVoucherRx
    • RelayRx Continuity of Care
    • Care4Today
    • Patient Advisor
    • 2net Mobile and 2net Platform
    • Pharmacy Health Connect
    • Prescription Reminder Service - Local Store Marketing
    • Medication Therapy Management Solution
  • 製藥/生物製藥公司採用的產品和技術
    • 智能藥丸的瓶,盒和蓋
    • 基於人工智能(AI)的產品
    • 直接監督治療(DOT)的自動化
    • 已連接的設備
    • 互動軟件
    • 智能噴油器
    • 移動應用程序/軟件
  • 藥物依從性市場:區域分析
    • 北美
      • 主要趨勢
      • 醫療系統對市場的影響
      • 預測分析
    • 歐洲
    • 亞太地區
    • 拉丁美洲
  • 違規對臨床試驗的影響

第13章競爭情況

  • 主要公司和主要產品/服務的列表
  • 主要公司的市場佔有率分析
  • 主要公司的相互比較
  • 主要公司的戰略發展狀況
    • 推出產品/服務
    • 合作夥伴
    • 投資
    • 其他趨勢

第14章公司簡介

  • Koninklijke Philips N.V.
  • Qualcomm Incorporated
  • AdhereTech Inc.
  • McKesson Corporation
  • Omnicell Inc.
  • SMRxT Inc.
  • DrFirst.com Inc.
  • Cardinal Health Inc.
  • Johnson & Johnson Services Inc.

第15章附錄

目錄
Product Code: LS10138

Title:
Medication Adherence Market Research Report: By Product (Software Centric, Hardware Centric), Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Respiratory, Gastrointestinal, Rheumatology) - Global Industry Analysis and Growth Forecast to 2030.

Every year, cardiovascular diseases kill 17.9 million people, while cancer claims 9.6 million human victims. These statistics by the World Health Organization (WHO) clearly reflect the burden of chronic diseases, which continues to rise. As a result, the global medication adherence market, which generated $2,310.0 million in 2019, is predicted to grow at a robust 15.5% CAGR between 2020 and 2030, to reach $11,226.3 million in 2030, according to P&S Intelligence.

All chronic diseases require prolonged treatment, medication, and monitoring and strict adherence to the medication schedule. The increasing awareness about taking medication as and when directed is the key reason behind the medication adherence market advance. Non-adherence or poor adherence to the medication schedule adds $177 billion to the global healthcare expenditure and results in 25% of all hospitalizations and 50% of all treatment failures each year.

During the COVID-19 pandemic, the medication adherence market is receiving a boost, majorly due to the rapidly rising case and death count attributed to this viral infection. Out of fear of contracting the infection and dying of it due to poor medication adherence, people are rapidly adopting medication adherence solutions. As per a study done on 7,578 patients using controller inhalers, as well as the Propeller Health medication adherence solution, medication adherence rate rose by 14.9% between the first seven days of January 2020 and the last seven days of March 2020.

North America is the most productive region in the medication adherence market presently. As per the CDC, seven in every 10 deaths in the U.S. in 2019 were because of chronic diseases. Apart from the rising prevalence of such medical issues, the geriatric population, healthcare expenditure, and R&D spending on healthcare technologies are increasing in the region. The rising geriatric population is leading to the increasing incidence of chronic diseases, thereby driving the demand for medication adherence solutions.

Over the next 10 years, the medication adherence market will observe the highest CAGR in the Asia-Pacific (APAC) region. The increasing disposable income of the population here is allowing them to go for expensive treatments, as well as medication adherence solutions. Moreover, market players in the region are bringing about technological enhancements in these solutions, for bettering the treatment outcomes. Numerous initiatives have been taken to technologically enhance these solutions, such as those currently underway in Australia and Singapore.

The major companies in the global medication adherence market are: Qualcomm Incorporated, Koninklijke Philips N.V., McKesson Corporation, AdhereTech Inc., SMRxT Inc., Omnicell Inc., Cardinal Health Inc., DrFirst.com Inc., and Johnson & Johnson Services Inc.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Product
    • 1.3.2 Market Segmentation by Medication
    • 1.3.3 Market Segmentation by Region
    • 1.3.4 Analysis Period
    • 1.3.5 Market Data Reporting Unit
      • 1.3.5.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
    • 2.1.1 Paid
    • 2.1.2 Unpaid
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Currency Conversion Rates
  • 2.6 Assumptions for the Study

Chapter 3. Executive Summary

  • 3.1 Voice of Industry Experts/KOLs

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Product
      • 4.1.1.1 Software centric
        • 4.1.1.1.1 Mobile apps
        • 4.1.1.1.2 Others
      • 4.1.1.2 Hardware centric
        • 4.1.1.2.1 Devices
        • 4.1.1.2.1.1 Automated dispensing systems
        • 4.1.1.2.1.2 Smart pill bottles
        • 4.1.1.2.1.3 Electronic trays
        • 4.1.1.2.1.4 Others
        • 4.1.1.2.2 Packaging
        • 4.1.1.2.2.1 Multi dose
        • 4.1.1.2.2.2 Unit dose
    • 4.1.2 By Medication
      • 4.1.2.1 Cardiovascular
      • 4.1.2.2 CNS
      • 4.1.2.3 Diabetes
      • 4.1.2.4 Oncology
      • 4.1.2.5 Respiratory
      • 4.1.2.6 Gastrointestinal
      • 4.1.2.7 Rheumatology
      • 4.1.2.8 Others
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing use of medication adherence apps
      • 4.2.1.2 Rising awareness for medication adherence through patient saving programs
      • 4.2.1.3 Growing popularity of medication adherence systems and software
    • 4.2.2 Drivers
      • 4.2.2.1 Growing demand for advanced medication adherence systems
      • 4.2.2.2 Increasing prevalence of chronic diseases
      • 4.2.2.3 Rising geriatric population
      • 4.2.2.4 Increasing demand for mHealth technologies
      • 4.2.2.5 Expanding demand for personalized healthcare
      • 4.2.2.6 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 Privacy and security concerns in the EHR and e-prescribing-based medication adherence systems
      • 4.2.3.2 Inadequate healthcare infrastructure in developing economies
      • 4.2.3.3 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Vast unexplored medication adherence market across the globe
  • 4.3 Impact of COVID-19 on Medication Adherence Market
    • 4.3.1 COVID-19 Scenario
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Intensity of Rivalry
    • 4.4.4 Threat of New Entrants
    • 4.4.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

  • 5.1 By Product
    • 5.1.1 Software Centric Medication Adherence Market, by Type
    • 5.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 5.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 5.2 By Medication
  • 5.3 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Product
    • 6.1.1 Software Centric Medication Adherence Market, by Type
    • 6.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 6.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 6.2 By Medication
  • 6.3 By Country

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Product
    • 7.1.1 Software Centric Medication Adherence Market, by Type
    • 7.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 7.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 7.2 By Medication
  • 7.3 By Country

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Product
    • 8.1.1 Software Centric Medication Adherence Market, by Type
    • 8.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 8.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 8.2 By Medication
  • 8.3 By Country

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Product
    • 9.1.1 Software Centric Medication Adherence Market, by Type
    • 9.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 9.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 9.2 By Medication
  • 9.3 By Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Product
    • 10.1.1 Software Centric Medication Adherence Market, by Type
    • 10.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 10.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 10.2 By Medication
  • 10.3 By Country

Chapter 11. Major Markets for Medication Adherence

  • 11.1 U.S. Medication Adherence Market
    • 11.1.1 By Product
      • 11.1.1.1 Software centric medication adherence market, by type
      • 11.1.1.2 Hardware centric medication adherence market, by devices
      • 11.1.1.3 Hardware centric medication adherence market, by packaging
    • 11.1.2 By Medication
  • 11.2 Canada Medication Adherence Market
    • 11.2.1 By Product
      • 11.2.1.1 Software centric medication adherence market, by type
      • 11.2.1.2 Hardware centric medication adherence market, by devices
      • 11.2.1.3 Hardware centric medication adherence market, by packaging
    • 11.2.2 By Medication
  • 11.3 Germany Medication Adherence Market
    • 11.3.1 By Product
      • 11.3.1.1 Software centric medication adherence market, by type
      • 11.3.1.2 Hardware centric medication adherence market, by devices
      • 11.3.1.3 Hardware centric medication adherence market, by packaging
    • 11.3.2 By Medication
  • 11.4 France Medication Adherence Market
    • 11.4.1 By Product
      • 11.4.1.1 Software centric medication adherence market, by type
      • 11.4.1.2 Hardware centric medication adherence market, by devices
      • 11.4.1.3 Hardware centric medication adherence market, by packaging
    • 11.4.2 By Medication
  • 11.5 Spain Medication Adherence Market
    • 11.5.1 By Product
      • 11.5.1.1 Software centric medication adherence market, by type
      • 11.5.1.2 Hardware centric medication adherence market, by devices
      • 11.5.1.3 Hardware centric medication adherence market, by packaging
    • 11.5.2 By Medication
  • 11.6 U.K. Medication Adherence Market
    • 11.6.1 By Product
      • 11.6.1.1 Software centric medication adherence market, by type
      • 11.6.1.2 Hardware centric medication adherence market, by devices
      • 11.6.1.3 Hardware centric medication adherence market, by packaging
    • 11.6.2 By Medication
  • 11.7 Italy Medication Adherence Market
    • 11.7.1 By Product
      • 11.7.1.1 Software centric medication adherence market, by type
      • 11.7.1.2 Hardware centric medication adherence market, by devices
      • 11.7.1.3 Hardware centric medication adherence market, by packaging
    • 11.7.2 By Medication
  • 11.8 Japan Medication Adherence Market
    • 11.8.1 By Product
      • 11.8.1.1 Software centric medication adherence market, by type
      • 11.8.1.2 Hardware centric medication adherence market, by devices
      • 11.8.1.3 Hardware centric medication adherence market, by packaging
    • 11.8.2 By Medication
  • 11.9 China Medication Adherence Market
    • 11.9.1 By Product
      • 11.9.1.1 Software centric medication adherence market, by type
      • 11.9.1.2 Hardware centric medication adherence market, by devices
      • 11.9.1.3 Hardware centric medication adherence market, by packaging
    • 11.9.2 By Medication
  • 11.10 India Medication Adherence Market
    • 11.10.1 By Product
      • 11.10.1.1 Software centric medication adherence market, by type
      • 11.10.1.2 Hardware centric medication adherence market, by devices
      • 11.10.1.3 Hardware centric medication adherence market, by packaging
    • 11.10.2 By Medication

Chapter 12. Medication Adherence Product Analysis

  • 12.1 Hardware-Centric Products
    • 12.1.1 Philips Automated Medication Dispenser
      • 12.1.1.1 Overview
      • 12.1.1.2 Pros
      • 12.1.1.3 Cons
    • 12.1.2 2net Hub
      • 12.1.2.1 Overview
      • 12.1.2.2 Pros
      • 12.1.2.3 Cons
    • 12.1.3 Omnicell XT
      • 12.1.3.1 Overview
      • 12.1.3.2 Pros
      • 12.1.3.3 Cons
    • 12.1.4 Smart Pill Bottle
      • 12.1.4.1 Overview
      • 12.1.4.2 Pros
      • 12.1.4.3 Cons
    • 12.1.5 Nomi Pill Bottle
      • 12.1.5.1 Overview
      • 12.1.5.2 Pros
      • 12.1.5.3 Cons
    • 12.1.6 Cardinal Health Repackaging Solutions
      • 12.1.6.1 Overview
      • 12.1.6.2 Pros
      • 12.1.6.3 Cons
    • 12.1.7 Dispill
      • 12.1.7.1 Overview
      • 12.1.7.2 Pros
      • 12.1.7.3 Cons
  • 12.2 Software-Centric Products
    • 12.2.1 RelayRx PriorAuthPlus
      • 12.2.1.1 Overview
      • 12.2.1.2 Pros
      • 12.2.1.3 Cons
    • 12.2.2 Adherence Performance Solution
      • 12.2.2.1 Overview
      • 12.2.2.2 Pros
      • 12.2.2.3 Cons
    • 12.2.3 eVoucherRx
      • 12.2.3.1 Overview
      • 12.2.3.2 Pros
      • 12.2.3.3 Cons
    • 12.2.4 RelayRx Continuity of Care
      • 12.2.4.1 Overview
      • 12.2.4.2 Pros
      • 12.2.4.3 Cons
    • 12.2.5 Care4Today
      • 12.2.5.1 Overview
      • 12.2.5.2 Pros
      • 12.2.5.3 Cons
    • 12.2.6 Patient Advisor
      • 12.2.6.1 Overview
      • 12.2.6.2 Pros
      • 12.2.6.3 Cons
    • 12.2.7 2net Mobile and 2net Platform
      • 12.2.7.1 Overview
      • 12.2.7.2 Pros
      • 12.2.7.3 Cons
    • 12.2.8 Pharmacy Health Connect
      • 12.2.8.1 Overview
      • 12.2.8.2 Pros
      • 12.2.8.3 Cons
    • 12.2.9 Prescription Reminder Service - Local Store Marketing
      • 12.2.9.1 Overview
      • 12.2.9.2 Pros
      • 12.2.9.3 Cons
    • 12.2.10 Medication Therapy Management Solution
      • 12.2.10.1 Overview
      • 12.2.10.2 Pros
      • 12.2.10.3 Cons
  • 12.3 Products/Technologies Adopted by Pharmaceutical/ Biopharmaceutical Companies
    • 12.3.1 Smart Pill Bottles, Boxes, and Caps
    • 12.3.2 AI-Based Products
    • 12.3.3 Automation of Directly Observed Therapy (DOT)
    • 12.3.4 Connected Devices
    • 12.3.5 Interactive Software
    • 12.3.6 Smart Injectors
    • 12.3.7 Mobile Applications/Software
  • 12.4 Regional Analysis of Medication Adherence Market
    • 12.4.1 North America
      • 12.4.1.1 Key trends
      • 12.4.1.2 Impact of the healthcare system on the market
      • 12.4.1.3 Forecast analysis
    • 12.4.2 Europe
      • 12.4.2.1 Key trends
      • 12.4.2.2 Impact of the healthcare system on the market
      • 12.4.2.3 Forecast analysis
    • 12.4.3 APAC
      • 12.4.3.1 Key trends
      • 12.4.3.2 Impact of the healthcare system on the market
      • 12.4.3.3 Forecast analysis
    • 12.4.4 LATAM
      • 12.4.4.1 Key trends
      • 12.4.4.2 Impact of the healthcare system on the market
      • 12.4.4.3 Forecast analysis
  • 12.5 Impact of Non-Adherence on Clinical Trials

Chapter 13. Competitive Landscape

  • 13.1 List of Players and Their Offerings
  • 13.2 Market Share Analysis of Key Players
  • 13.3 Competitive Benchmarking of Key Players
  • 13.4 Strategic Developments of Key Players
    • 13.4.1 Product/Service Launches
    • 13.4.2 Partnerships
    • 13.4.3 Investments
    • 13.4.4 Other Developments

Chapter 14. Company Profiles

  • 14.1 Koninklijke Philips N.V.
    • 14.1.1 Business Overview
    • 14.1.2 Product and Service Offerings
    • 14.1.3 Key Financial Summary
  • 14.2 Qualcomm Incorporated
    • 14.2.1 Business Overview
    • 14.2.2 Product and Service Offerings
    • 14.2.3 Key Financial Summary
  • 14.3 AdhereTech Inc.
    • 14.3.1 Business Overview
    • 14.3.2 Product and Service Offerings
  • 14.4 McKesson Corporation
    • 14.4.1 Business Overview
    • 14.4.2 Product and Service Offerings
    • 14.4.3 Key Financial Summary
  • 14.5 Omnicell Inc.
    • 14.5.1 Business Overview
    • 14.5.2 Product and Service Offerings
    • 14.5.3 Key Financial Summary
  • 14.6 SMRxT Inc.
    • 14.6.1 Business Overview
    • 14.6.2 Product and Service Offerings
    • 14.6.3 Strategic Growth Plans
  • 14.7 DrFirst.com Inc.
    • 14.7.1 Business Overview
    • 14.7.2 Product and Service Offerings
  • 14.8 Cardinal Health Inc.
    • 14.8.1 Business Overview
    • 14.8.2 Product and Service Offerings
    • 14.8.3 Key Financial Summary
  • 14.9 Johnson & Johnson Services Inc.
    • 14.9.1 Business Overview
    • 14.9.2 Product and Service Offerings
    • 14.9.3 Key Financial Summary

Chapter 15. Appendix

  • 15.1 Abbreviations
  • 15.2 Sources and References
  • 15.3 Related Reports

LIST OF TABLES

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 COVID-19 IMPACT ANALYSIS ON DIFFERENT SECTORS
  • TABLE 5 GLOBAL MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 6 GLOBAL MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 7 GLOBAL SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 8 GLOBAL SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 9 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 10 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 11 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 12 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 13 GLOBAL MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 14 GLOBAL MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 15 GLOBAL MEDICATION ADHERENCE MARKET, BY REGION, $M (2014-2019)
  • TABLE 16 GLOBAL MEDICATION ADHERENCE MARKET, BY REGION, $M (2020-2030)
  • TABLE 17 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 18 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 19 NORTH AMERICA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 20 NORTH AMERICA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 21 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 22 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 23 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 24 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 25 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 26 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 27 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 28 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 29 EUROPE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 30 EUROPE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 31 EUROPE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 32 EUROPE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 33 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 34 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 35 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 36 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 37 EUROPE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 38 EUROPE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 39 EUROPE MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 40 EUROPE MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 41 APAC MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 42 APAC MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 43 APAC SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 44 APAC SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 45 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 46 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 47 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 48 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 49 APAC MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 50 APAC MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 51 APAC MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 52 APAC MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 53 LATAM MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 54 LATAM MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 55 LATAM SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 56 LATAM SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 57 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 58 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 59 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 60 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 61 LATAM MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 62 LATAM MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 63 LATAM MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 64 LATAM MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 65 MEA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 66 MEA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 67 MEA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 68 MEA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 69 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 70 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 71 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 72 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 73 MEA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 74 MEA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 75 MEA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 76 MEA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 77 U.S. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 78 U.S. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 79 U.S. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 80 U.S. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 81 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 82 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 83 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 84 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 85 U.S. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 86 U.S. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 87 CANADA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 88 CANADA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 89 CANADA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 90 CANADA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 91 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 92 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 93 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 94 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 95 CANADA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 96 CANADA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 97 GERMANY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 98 GERMANY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 99 GERMANY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 100 GERMANY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 101 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 102 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 103 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 104 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 105 GERMANY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 106 GERMANY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 107 FRANCE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 108 FRANCE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 109 FRANCE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 110 FRANCE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 111 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 112 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 113 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 114 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 115 FRANCE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 116 FRANCE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 117 SPAIN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 118 SPAIN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 119 SPAIN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 120 SPAIN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 121 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 122 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 123 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 124 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 125 SPAIN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 126 SPAIN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 127 U.K. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 128 U.K. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 129 U.K. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 130 U.K. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 131 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 132 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 133 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 134 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 135 U.K. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 136 U.K. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 137 ITALY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 138 ITALY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 139 ITALY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 140 ITALY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 141 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 142 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 143 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 144 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 145 ITALY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 146 ITALY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 147 JAPAN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 148 JAPAN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 149 JAPAN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 150 JAPAN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 151 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 152 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 153 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 154 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 155 JAPAN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 156 JAPAN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 157 CHINA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 158 CHINA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 159 CHINA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 160 CHINA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 161 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 162 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 163 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 164 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 165 CHINA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 166 CHINA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 167 INDIA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 168 INDIA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 169 INDIA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 170 INDIA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 171 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 172 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 173 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 174 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 175 INDIA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 176 INDIA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 177 LIST OF PLAYERS AND THEIR OFFERINGS
  • TABLE 178 KONINKLIJKE PHILIPS N.V. - AT A GLANCE
  • TABLE 179 KONINKLIJKE PHILIPS N.V. - KEY FINANCIAL SUMMARY
  • TABLE 180 QUALCOMM INCORPORATED - AT A GLANCE
  • TABLE 181 QUALCOMM INCORPORATED - KEY FINANCIAL SUMMARY
  • TABLE 182 ADHERETECH INC. - AT A GLANCE
  • TABLE 183 MCKESSON CORPORATION - AT A GLANCE
  • TABLE 184 MCKESSON CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 185 OMNICELL INC. - AT A GLANCE
  • TABLE 186 OMNICELL INC. - KEY FINANCIAL SUMMARY
  • TABLE 187 SMRXT INC. - AT A GLANCE
  • TABLE 188 DRFIRST.COM INC. - AT A GLANCE
  • TABLE 189 CARDINAL HEALTH INC. - AT A GLANCE
  • TABLE 190 CARDINAL HEALTH INC. - KEY FINANCIAL SUMMARY
  • TABLE 191 JOHNSON & JOHNSON SERVICES INC. - AT A GLANCE
  • TABLE 192 JOHNSON & JOHNSON SERVICES INC. - KEY FINANCIAL SUMMARY

LIST OF FIGURES

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 6 DATA TRIANGULATION APPROACH
  • FIG 7 CURRENCY CONVERSION RATES FOR USD (2019)
  • FIG 8 GLOBAL MEDICATION ADHERENCE MARKET SUMMARY
  • FIG 9 OPINION OF INDUSTRY EXPERTS/KOLS
  • FIG 10 AGING POPULATION AS A PERCENTAGE OF TOTAL REGION POPULATION
  • FIG 11 MAJOR CATEGORIES OF MHEALTH APPLICATIONS AND MEDICATION ADHERENCE
  • FIG 12 PORTER'S FIVE FORCES ANALYSIS
  • FIG 13 GLOBAL MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 14 GLOBAL SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 15 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 16 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 17 GLOBAL MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 18 WORLDWIDE MAJOR MARKETS FOR MEDICATION ADHERENCE
  • FIG 19 NORTH AMERICA MEDICATION ADHERENCE MARKET SNAPSHOT
  • FIG 20 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 21 NORTH AMERICA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 22 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 23 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 24 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 25 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 26 EUROPE MEDICATION ADHERENCE MARKET SNAPSHOT
  • FIG 27 EUROPE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 28 EUROPE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 29 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 30 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 31 EUROPE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 32 EUROPE MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 33 APAC MEDICATION ADHERENCE MARKET SNAPSHOT
  • FIG 34 APAC MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 35 APAC SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 36 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 37 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 38 APAC MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 39 APAC MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 40 LATAM MEDICATION ADHERENCE MARKET SNAPSHOT
  • FIG 41 LATAM MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 42 LATAM SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 43 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 44 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 45 LATAM MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 46 LATAM MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 47 MEA MEDICATION ADHERENCE MARKET SNAPSHOT
  • FIG 48 MEA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 49 MEA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 50 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 51 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 52 MEA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 53 MEA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 54 U.S. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 55 U.S. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 56 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 57 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 58 U.S. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 59 CANADA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 60 CANADA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 61 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 62 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 63 CANADA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 64 GERMANY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 65 GERMANY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 66 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 67 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 68 GERMANY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 69 FRANCE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 70 FRANCE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 71 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 72 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 73 FRANCE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 74 SPAIN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 75 SPAIN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 76 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 77 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 78 SPAIN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 79 U.K. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 80 U.K. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 81 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 82 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 83 U.K. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 84 ITALY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 85 ITALY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 86 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 87 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 88 ITALY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 89 JAPAN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 90 JAPAN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 91 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 92 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 93 JAPAN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 94 CHINA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 95 CHINA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 96 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 97 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 98 CHINA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 99 INDIA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 100 INDIA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 101 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 102 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 103 INDIA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 104 GLOBAL MEDICATION ADHERENCE MARKET SHARE OF KEY PLAYERS (2019)
  • FIG 105 COMPETITIVE BENCHMARKING OF KEY PLAYERS
  • FIG 106 KONINKLIJKE PHILIPS N.V. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 107 QUALCOMM INCORPORATED - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 108 MCKESSON CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 109 OMNICELL INC. - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 110 CARDINAL HEALTH INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 111 JOHNSON & JOHNSON SERVICES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)